Correlation Between Bolt Biotherapeutics and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bolt Biotherapeutics and Akari Therapeutics PLC, you can compare the effects of market volatilities on Bolt Biotherapeutics and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and Akari Therapeutics.
Diversification Opportunities for Bolt Biotherapeutics and Akari Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bolt and Akari is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Bolt Biotherapeutics and Akari Therapeutics
Given the investment horizon of 90 days Bolt Biotherapeutics is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bolt Biotherapeutics is 2.02 times less risky than Akari Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 121.00 in Akari Therapeutics PLC on November 2, 2024 and sell it today you would earn a total of 11.00 from holding Akari Therapeutics PLC or generate 9.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bolt Biotherapeutics vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Bolt Biotherapeutics |
| Akari Therapeutics PLC |
Bolt Biotherapeutics and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bolt Biotherapeutics and Akari Therapeutics
The main advantage of trading using opposite Bolt Biotherapeutics and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |